Total Payments
$19,470
2024 Payments
$3,498
Companies
25
Transactions
1,282
Medicare Patients
5,498
Medicare Billing
$975,559
Payment Breakdown by Category
Food & Beverage$19,025 (97.7%)
Education$445.67 (2.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $19,025 | 1,272 | 97.7% |
| Education | $445.67 | 10 | 2.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $5,596 | 353 | $0 (2024) |
| ViiV Healthcare Company | $4,039 | 316 | $0 (2024) |
| Janssen Biotech, Inc. | $1,974 | 200 | $0 (2023) |
| Insmed, Inc. | $1,546 | 69 | $0 (2024) |
| Merck Sharp & Dohme LLC | $1,527 | 74 | $0 (2024) |
| ABBVIE INC. | $1,159 | 68 | $0 (2024) |
| Melinta Therapeutics, LLC | $728.19 | 45 | $0 (2024) |
| Theratechnologies Inc. | $644.93 | 30 | $0 (2024) |
| Paratek Pharmaceuticals, Inc. | $488.80 | 25 | $0 (2024) |
| Allergan, Inc. | $397.48 | 37 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,498 | 203 | ViiV Healthcare Company ($1,112) |
| 2023 | $2,967 | 174 | Gilead Sciences, Inc. ($1,030) |
| 2022 | $2,977 | 186 | Gilead Sciences, Inc. ($869.45) |
| 2021 | $2,764 | 198 | Gilead Sciences, Inc. ($651.70) |
| 2020 | $2,695 | 175 | Gilead Sciences, Inc. ($711.80) |
| 2019 | $1,496 | 116 | Gilead Sciences, Inc. ($360.89) |
| 2018 | $1,522 | 108 | ViiV Healthcare Company ($485.60) |
| 2017 | $1,551 | 122 | Gilead Sciences Inc ($539.13) |
All Payment Transactions
1,282 individual payment records from CMS Open Payments — Page 1 of 52
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Theratechnologies Inc. | EGRIFTA (Drug), TROGARZO | Food and Beverage | In-kind items and services | $30.01 | General |
| Category: HIV | ||||||
| 12/16/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $25.95 | General |
| 12/12/2024 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $26.65 | General |
| Category: Infections and Infectious Diseases | ||||||
| 12/10/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $71.10 | General |
| Category: HIV | ||||||
| 12/10/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: Respiratory | ||||||
| 12/10/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $1.61 | General |
| Category: HIV | ||||||
| 12/04/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $23.17 | General |
| Category: HIV | ||||||
| 12/03/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DELSTRIGO | Food and Beverage | In-kind items and services | $24.52 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/02/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: HIV | ||||||
| 12/02/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $1.35 | General |
| Category: HIV | ||||||
| 11/27/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: HIV | ||||||
| 11/27/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $4.10 | General |
| Category: HIV | ||||||
| 11/25/2024 | Theratechnologies Inc. | EGRIFTA (Drug), TROGARZO | Food and Beverage | In-kind items and services | $24.12 | General |
| Category: HIV | ||||||
| 11/21/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $27.01 | General |
| Category: HIV | ||||||
| 11/21/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $1.12 | General |
| Category: HIV | ||||||
| 11/20/2024 | ABBVIE INC. | AVYCAZ (Drug), DALVANCE, TEFLARO | Food and Beverage | In-kind items and services | $26.50 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/20/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.35 | General |
| 11/19/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $2.42 | General |
| 11/18/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $27.70 | General |
| 11/14/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: Respiratory | ||||||
| 11/13/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $26.80 | General |
| 11/12/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: ANTIBIOTIC | ||||||
| 11/07/2024 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: Infections and Infectious Diseases | ||||||
| 11/05/2024 | Melinta Therapeutics, LLC | Rezzayo (Drug), Kimyrsa | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: ANTIFUNGALS | ||||||
| 11/04/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $27.72 | General |
| Category: HIV | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 1,320 | 2,618 | $387,600 | $265,734 |
| 2022 | 11 | 1,156 | 2,114 | $308,965 | $199,179 |
| 2021 | 11 | 1,392 | 2,513 | $343,480 | $222,371 |
| 2020 | 14 | 1,630 | 3,427 | $485,035 | $288,276 |
Total Patients
5,498
Total Services
10,672
Medicare Billing
$975,559
Procedure Codes
47
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 407 | 1,203 | $150,375 | $119,683 | 79.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 189 | 410 | $65,600 | $42,481 | 64.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 221 | 248 | $42,160 | $26,976 | 64.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 161 | 401 | $38,095 | $26,508 | 69.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 162 | 163 | $40,750 | $23,669 | 58.1% |
| 36590 | Removal of central venous tube with port or pump | Office | 2023 | 41 | 46 | $16,100 | $8,696 | 54.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 41 | 41 | $12,300 | $5,713 | 46.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 30 | 30 | $10,500 | $5,425 | 51.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 16 | 16 | $5,600 | $2,945 | 52.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 28 | 33 | $3,960 | $2,477 | 62.5% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 24 | 27 | $2,160 | $1,161 | 53.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 348 | 922 | $115,250 | $78,694 | 68.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 270 | 297 | $50,490 | $33,741 | 66.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 141 | 255 | $40,800 | $26,542 | 65.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 136 | 337 | $32,015 | $19,996 | 62.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 73 | 73 | $18,250 | $12,065 | 66.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 42 | 42 | $14,700 | $7,792 | 53.0% |
| 36590 | Removal of central venous tube with port or pump | Office | 2022 | 32 | 32 | $11,200 | $6,394 | 57.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 40 | 65 | $7,800 | $4,760 | 61.0% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 26 | 40 | $8,000 | $4,118 | 51.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 29 | 29 | $8,700 | $4,107 | 47.2% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 19 | 22 | $1,760 | $969.57 | 55.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 423 | 901 | $112,625 | $78,009 | 69.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 389 | 435 | $73,950 | $49,592 | 67.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 246 | 745 | $70,775 | $45,050 | 63.7% |
About Dr. Jose Menajovsky, MD
Dr. Jose Menajovsky, MD is a Infectious Disease healthcare provider based in West Palm Beach, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/26/2008. The National Provider Identifier (NPI) number assigned to this provider is 1720231459.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jose Menajovsky, MD has received a total of $19,470 in payments from pharmaceutical and medical device companies, with $3,498 received in 2024. These payments were reported across 1,282 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($19,025).
As a Medicare-enrolled provider, Menajovsky has provided services to 5,498 Medicare beneficiaries, totaling 10,672 services with total Medicare billing of $975,559. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Location West Palm Beach, FL
- Active Since 10/26/2008
- Last Updated 04/03/2018
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1720231459
Products in Payments
- SYMTUZA (Drug) $1,735
- DOVATO (Drug) $1,719
- Arikayce (Drug) $1,466
- CABENUVA (Biological) $1,025
- AVYCAZ (Drug) $627.70
- DIFICID (Drug) $543.92
- EGRIFTA (Drug) $543.88
- PIFELTRO (Drug) $498.79
- NUZYRA (Drug) $488.80
- JULUCA (Drug) $468.21
- APRETUDE (Biological) $436.71
- TRIUMEQ (Drug) $333.29
- Mavyret (Drug) $303.08
- PREZCOBIX (Drug) $298.35
- ZERBAXA (Drug) $285.48
- Symtuza (Drug) $279.10
- MAVYRET (Drug) $275.66
- Orbactiv (Drug) $251.94
- Rezzayo (Drug) $251.41
- Fetroja (Drug) $248.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in West Palm Beach
Dr. Olayemi Osiyemi, Md, MD
Infectious Disease — Payments: $396,544
Infectious Disease $396,544
David Dodson, M.d, M.D
Infectious Disease — Payments: $2,418
Infectious Disease $2,418
George Carden, M.d, M.D
Infectious Disease — Payments: $2,355
Infectious Disease $2,355
James Morris, M.d, M.D
Infectious Disease — Payments: $122.41
Infectious Disease $122.41
Thomas Parrino, M.d, M.D
Infectious Disease
Infectious Disease